BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $635,844 | -22.9% | 16,848 | -6.9% | 0.01% | -20.0% |
| Q2 2023 | $824,545 | +6.4% | 18,098 | -5.3% | 0.02% | 0.0% |
| Q1 2023 | $774,777 | -35.7% | 19,102 | -19.2% | 0.02% | -40.0% |
| Q4 2022 | $1,205,134 | -5.7% | 23,644 | -0.3% | 0.02% | -13.8% |
| Q3 2022 | $1,278,000 | -16.1% | 23,719 | 0.0% | 0.03% | -9.4% |
| Q2 2022 | $1,524,000 | -20.2% | 23,719 | -3.7% | 0.03% | -5.9% |
| Q1 2022 | $1,910,000 | -9.9% | 24,628 | -0.3% | 0.03% | 0.0% |
| Q4 2021 | $2,121,000 | +0.1% | 24,703 | -6.3% | 0.03% | -10.5% |
| Q3 2021 | $2,119,000 | -0.1% | 26,353 | 0.0% | 0.04% | -2.6% |
| Q2 2021 | $2,121,000 | -1.3% | 26,353 | +3.5% | 0.04% | -9.3% |
| Q1 2021 | $2,149,000 | +0.4% | 25,471 | -4.5% | 0.04% | -6.5% |
| Q4 2020 | $2,140,000 | -13.5% | 26,671 | -13.4% | 0.05% | -24.6% |
| Q3 2020 | $2,475,000 | -7.3% | 30,783 | -0.7% | 0.06% | -14.1% |
| Q2 2020 | $2,669,000 | +20.3% | 31,000 | +13.4% | 0.07% | -2.7% |
| Q1 2020 | $2,219,000 | -3.3% | 27,325 | -0.4% | 0.07% | +17.7% |
| Q4 2019 | $2,294,000 | -4.3% | 27,435 | +0.1% | 0.06% | -11.4% |
| Q3 2019 | $2,396,000 | +11.4% | 27,397 | +4.4% | 0.07% | +7.7% |
| Q2 2019 | $2,150,000 | +4.4% | 26,252 | +3.6% | 0.06% | -1.5% |
| Q1 2019 | $2,060,000 | +23.4% | 25,333 | -0.1% | 0.07% | +4.8% |
| Q4 2018 | $1,670,000 | -11.6% | 25,370 | +3.5% | 0.06% | +5.0% |
| Q3 2018 | $1,889,000 | -12.6% | 24,501 | -16.3% | 0.06% | -18.9% |
| Q2 2018 | $2,162,000 | +296.7% | 29,276 | +249.6% | 0.07% | +252.4% |
| Q1 2018 | $545,000 | -6.0% | 8,375 | -6.7% | 0.02% | -4.5% |
| Q4 2017 | $580,000 | +1.8% | 8,975 | -1.2% | 0.02% | 0.0% |
| Q3 2017 | $570,000 | +6.7% | 9,087 | +2.9% | 0.02% | +4.8% |
| Q2 2017 | $534,000 | +6.6% | 8,827 | -8.7% | 0.02% | +5.0% |
| Q1 2017 | $501,000 | -10.2% | 9,667 | -23.2% | 0.02% | -13.0% |
| Q4 2016 | $558,000 | +12.0% | 12,584 | +20.3% | 0.02% | +9.5% |
| Q3 2016 | $498,000 | +12.4% | 10,463 | +6.8% | 0.02% | +5.0% |
| Q2 2016 | $443,000 | +16.6% | 9,797 | +6.1% | 0.02% | +17.6% |
| Q1 2016 | $380,000 | -13.2% | 9,230 | -19.6% | 0.02% | -15.0% |
| Q4 2015 | $438,000 | +63.4% | 11,480 | +40.2% | 0.02% | +53.8% |
| Q3 2015 | $268,000 | -65.3% | 8,190 | -25.8% | 0.01% | -62.9% |
| Q2 2015 | $772,000 | +14.7% | 11,045 | +12.7% | 0.04% | +12.9% |
| Q1 2015 | $673,000 | +0.7% | 9,798 | +7.3% | 0.03% | -6.1% |
| Q4 2014 | $668,000 | -3.6% | 9,132 | -5.2% | 0.03% | -5.7% |
| Q3 2014 | $693,000 | -4.0% | 9,632 | -3.6% | 0.04% | -5.4% |
| Q2 2014 | $722,000 | +2.8% | 9,988 | +4.7% | 0.04% | -5.1% |
| Q1 2014 | $702,000 | +19.4% | 9,537 | +12.9% | 0.04% | +21.9% |
| Q4 2013 | $588,000 | +9.5% | 8,447 | +3.3% | 0.03% | +3.2% |
| Q3 2013 | $537,000 | -4.1% | 8,174 | +0.7% | 0.03% | -3.1% |
| Q2 2013 | $560,000 | – | 8,115 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |